Abstract

The induction and action of type I interferon (IFN) is of fundamental importance in human immune defenses toward microbial pathogens, particularly viruses. Basic discoveries within the molecular and cellular signaling pathways regulating type I IFN induction and downstream actions have shown the essential role of the IFN regulatory factor (IRF) and the signal transducer and activator of transcription (STAT) families, respectively. However, the exact biological and immunological functions of these factors have been most clearly revealed through the study of inborn errors of immunity and the resultant infectious phenotypes in humans. The spectrum of human inborn errors of immunity caused by mutations in IRFs and STATs has proven very diverse. These diseases encompass herpes simplex encephalitis (HSE) and severe influenza in IRF3- and IRF7/IRF9 deficiency, respectively. They also include Mendelian susceptibility to mycobacterial infection (MSMD) in STAT1 deficiency, through disseminated measles infection associated with STAT2 deficiency, and finally staphylococcal abscesses and chronic mucocutaneous candidiasis (CMC) classically described with Hyper-IgE syndrome (HIES) in the case of STAT3 deficiency. More recently, increasing focus has been on aspects of autoimmunity and autoinflammation playing an important part in many primary immunodeficiency diseases (PID)s, as exemplified by STAT1 gain-of-function causing CMC and autoimmune thyroiditis, as well as a recently described autoinflammatory syndrome with hypogammaglobulinemia and lymphoproliferation as a result of STAT3 gain-of-function. Here I review the infectious, inflammatory, and autoimmune disorders arising from mutations in IRF and STAT transcription factors in humans, highlightning the underlying molecular mechanisms and immunopathogenesis as well as the clinical/therapeutic perspectives of these new insights.

Highlights

  • Several decades of research uncovering the basic biology, regulation; and functions of the machinery for induction and responses to type I interferon (IFN) have paved the way for an understanding of a number of very diverse human diseases arising when one or more molecules in these pathways are defective

  • IFNAR1 and IFNAR2, leading to activation of the receptorassociated JAK1 and TYK2 kinases [11, 22, 25]. This is followed by recruitment and tyrosine phosphorylation of STAT1 and STAT2, which together with the transcription factor IRF9 form the heterotrimeric IFN-stimulated gene factor (ISGF)3 complex that binds to IFN-stimulated regulatory elements (ISRE) [26, 28, 29]

  • The infectious history of the patient, like the vast majority of previously described herpes simplex encephalitis (HSE) patients with defects in TLR3 signaling pathways, was notable for no previously reported increased susceptibility to other infections, suggesting specificity in the susceptibility to HSV-1 infection and development of central nervous system (CNS) infection [38]. This very narrow infectious phenotype caused by a defect of a transcription factor, which represents a point of convergence downstream of several IFN-inducing pattern recognition receptors (PRR) appears surprising

Read more

Summary

Frontiers in Immunology

The induction and action of type I interferon (IFN) is of fundamental importance in human immune defenses toward microbial pathogens, viruses. Basic discoveries within the molecular and cellular signaling pathways regulating type I IFN induction and downstream actions have shown the essential role of the IFN regulatory factor (IRF) and the signal transducer and activator of transcription (STAT) families, respectively. The spectrum of human inborn errors of immunity caused by mutations in IRFs and STATs has proven very diverse. These diseases encompass herpes simplex encephalitis (HSE) and severe influenza in IRF3- and IRF7/IRF9 deficiency, respectively. They include Mendelian susceptibility to mycobacterial infection (MSMD) in STAT1 deficiency, through disseminated measles infection associated with STAT2 deficiency, and staphylococcal abscesses and chronic mucocutaneous candidiasis (CMC) classically described with Hyper-IgE syndrome (HIES) in the case of STAT3 deficiency.

INTRODUCTION
Recognition of Microbial Pathogens and Induction of IFNs by IRFs
The Interferons
Severe influenza
DISEASES ASSOCIATED WITH DEFECTIVE STAT SIGNALING
DISEASES ASSOCIATED WITH EXCESSIVE STAT SIGNALING
PROPHYLAXIS AND TREATMENT OF DISEASES AFFECTING IRFs AND STATs
Findings
CONCLUSION AND FUTURE PERSPECTIVES
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.